Literature DB >> 12005167

Study of NADPH oxidase-activated sites in human neutrophils.

Harumichi Seguchi1, Toshihiro Kobayashi.   

Abstract

Neutrophils represent the first line of defence against invading microorganisms. An important part of this defence mechanism is the generation of superoxide (O2*-) and its reactive derivatives after stimulation by a variety of agents. This oxidant production is linked to the activation of NADPH oxidase, which is composed of cytosolic components (p47-phox and p67-phox) and membrane components (p22-phox and gp91-phox). Previous studies have shown that NADPH oxidase resides in the plasma membrane and the traditional view holds that cytoplasmic components of NADPH oxidase are brought into the neighbourhood of the plasma membrane and then conjugated with its membrane components upon stimulation. This review focuses on the evaluation of NADPH oxidase-activated sites in human neutrophils. Based on electron microscopic analysis, O2*- is first generated upon stimulation with certain stimulants, such as phorbol myristate acetate, within a specialized intracellular compartment containing alkaline phosphatase, and not on the plasma membrane, as previously thought. In addition, the cytosolic component of NADPH oxidase, p47-phox, accumulates at the juxtaposition of intracellular compartments but not of the plasma membrane. These results demonstrate that initial O2*- production occurs in an intracellular pool in human neutrophils. The oxidant-producing granules then bind directly to the plasma membrane or fuse to form larger structures that eventually become to be associated with the plasma membrane, and O2*- is released extracellularly from the neutrophils.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005167     DOI: 10.1093/jmicro/51.2.87

Source DB:  PubMed          Journal:  J Electron Microsc (Tokyo)        ISSN: 0022-0744


  8 in total

1.  Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase.

Authors:  Carlos H C Serezani; David M Aronoff; Sonia Jancar; Peter Mancuso; Marc Peters-Golden
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

Review 2.  New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signaling.

Authors:  Sabrina Bréchard; Sébastien Plançon; Eric J Tschirhart
Journal:  Antioxid Redox Signal       Date:  2012-09-18       Impact factor: 8.401

Review 3.  What really happens in the neutrophil phagosome?

Authors:  James K Hurst
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

4.  Mitochondrial transmembrane potential is diminished in phorbol myristate acetate-stimulated peritoneal resident macrophages isolated from wild-type mice, but not in those from gp91-phox-deficient mice.

Authors:  Toshihiro Kobayashi; Yasuhiro Ogawa; Yoshiya Watanabe; Masato Furuya; Sayo Kataoka; Eva Garcia del Saz; Shohko Tsunawaki; Mary C Dinauer; Harumichi Seguchi
Journal:  Histochem Cell Biol       Date:  2004-07-09       Impact factor: 4.304

5.  Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols.

Authors:  Mauricio Mora-Pale; Michel Weïwer; Jingjing Yu; Robert J Linhardt; Jonathan S Dordick
Journal:  Bioorg Med Chem       Date:  2009-05-30       Impact factor: 3.641

6.  Development of a caffeic acid-phthalimide hybrid compound for NADPH oxidase inhibition.

Authors:  Willian Henrique Dos Santos; Maurício Ikeda Yoguim; Regina Gomes Daré; Luiz Carlos da Silva-Filho; Sueli Oliveira Silva Lautenschlager; Valdecir Farias Ximenes
Journal:  RSC Adv       Date:  2021-05-18       Impact factor: 4.036

Review 7.  Regulation of superoxide production in neutrophils: role of calcium influx.

Authors:  Sabrina Bréchard; Eric J Tschirhart
Journal:  J Leukoc Biol       Date:  2008-06-10       Impact factor: 4.962

8.  Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction.

Authors:  Dimitrios Karathanassis; Robert V Stahelin; Jerónimo Bravo; Olga Perisic; Christine M Pacold; Wonhwa Cho; Roger L Williams
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.